No profile data available.
Retractable Technologies, Inc. (RVP) is a healthcare company in the additional medication administration equipment industry, based in Little Elm, United States, with about 195 full-time employees.
It reported revenue of $38.27 million for fiscal year 2025, up 15.8% from fiscal year 2024, and net income of -$12.80 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $7.18 million, down 13.5% from a year before. United States was its largest region in fiscal year 2025, with 84% of revenue. Its market capitalization was $20.81 million as of October 5, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 5, 2026.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Retractable Technologies reported $38.27 million in revenue for fiscal year 2025, up 15.8% from $33.05 million in fiscal year 2024. In Q1 2026 revenue was $7.18 million.
United States: 84% of revenue by region in fiscal year 2025, followed by North and South America (13%).
$20.81 million as of October 5, 2026.
Listed companies of a similar size in the same industry (additional medication administration equipment) include West Pharmaceutical Services, Inc. (WST), Stevanato Group S.p.A. (STVN), Embecta Corp. (EMBC), Biora Therapeutics, Inc. (BIOR).